Skip to main content
Erschienen in: European Journal of Nutrition 1/2022

28.07.2021 | Original Contribution

Temporal and mediation relations of weight loss, and changes in insulin resistance and blood pressure in response to 2-year weight-loss diet interventions: the POUNDS Lost trial

verfasst von: Liyuan Han, Tao Zhang, Dingyun You, Wei Chen, George Bray, Frank Sacks, Lu Qi

Erschienen in: European Journal of Nutrition | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Body weight and insulin resistance (IR) are closely correlated, and their temporal sequences in affecting blood pressure (BP) remain poorly defined. We examined the temporal sequences of weight loss and IR change, and their relations with BP in the Pounds Lost trial, a randomized weight-loss diet intervention study.

Methods

The present study included overweight/obese adults, who were randomized in a 2 × 2 factorial design to low-calorie diets containing 20 or 40% fat and 15 or 25% protein (diets with 65, 55, 45 and 35% carbohydrate). Weight, IR, systolic and diastolic BP levels were measured at baseline, 6 and 24 months. After excluding the subjects who took antihypertensive drugs, cross-lagged path and mediation analyses were performed among 540 participants.

Results

After adjusting for age, race, sex, and diet groups, the cross-lagged path coefficient from baseline weight to 24-month IR (β1 = 0.135, P = 0.04) was significantly greater than the path coefficient (β2 = 0.022, P > 0.05) from baseline IR to 24-month weight (P < 0.05 for the difference in βs), indicating that weight-loss preceded change of IR. The mediation effects of 24-month IR on the 24-month systolic BP and diastolic BP were estimated at 20.94% (P = 0.004) and 17.03% (P = 0.034), respectively.

Conclusions

Our data indicate that weight loss precedes change of IR, which mediates a significant proportion of the effects of weight loss on changes of BP in response to the diet interventions.

Trial registration

NCT00072995 First Posted November 17, 2003 Last Update Posted January 30, 2013 this study was not ‘retrospectively registered’.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Steinberger J et al (2003) Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 107(10):1448–1453CrossRef Steinberger J et al (2003) Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 107(10):1448–1453CrossRef
2.
Zurück zum Zitat McGill JB et al (2009) Progress and controversies: treating obesity and insulin resistance in the context of hypertension. J Clin Hypertens (Greenwich) 11(1):36–41CrossRef McGill JB et al (2009) Progress and controversies: treating obesity and insulin resistance in the context of hypertension. J Clin Hypertens (Greenwich) 11(1):36–41CrossRef
3.
Zurück zum Zitat Su HY et al (1995) Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals. Am J Hypertens 8(11):1067–1071CrossRef Su HY et al (1995) Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals. Am J Hypertens 8(11):1067–1071CrossRef
4.
Zurück zum Zitat Rocchini AP et al (1987) Insulin and blood pressure during weight loss in obese adolescents. Hypertension 10(3):267–273CrossRef Rocchini AP et al (1987) Insulin and blood pressure during weight loss in obese adolescents. Hypertension 10(3):267–273CrossRef
5.
Zurück zum Zitat Grassi G et al (1998) Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 97(20):2037–2042CrossRef Grassi G et al (1998) Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 97(20):2037–2042CrossRef
6.
Zurück zum Zitat Kuk JL, Lee S (2021) Assessing the utility of cardiorespiratory fitness, visceral fat, and liver fat in predicting changes in insulin sensitivity beyond simple changes in body weight after exercise training in adolescents. Appl Physiol Nutr Metab 46(1):55–62CrossRef Kuk JL, Lee S (2021) Assessing the utility of cardiorespiratory fitness, visceral fat, and liver fat in predicting changes in insulin sensitivity beyond simple changes in body weight after exercise training in adolescents. Appl Physiol Nutr Metab 46(1):55–62CrossRef
7.
Zurück zum Zitat Vadiveloo M et al (2016) Greater healthful dietary variety is associated with greater 2-year changes in weight and adiposity in the preventing overweight using novel dietary strategies (POUNDS Lost) trial. J Nutr 146(8):1552–1559CrossRef Vadiveloo M et al (2016) Greater healthful dietary variety is associated with greater 2-year changes in weight and adiposity in the preventing overweight using novel dietary strategies (POUNDS Lost) trial. J Nutr 146(8):1552–1559CrossRef
8.
Zurück zum Zitat Sacks FM et al (2009) Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 360(9):859–873CrossRef Sacks FM et al (2009) Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 360(9):859–873CrossRef
9.
Zurück zum Zitat Rubin DB (1990) Multiple imputation for nonresponse in surveys. Springer Rubin DB (1990) Multiple imputation for nonresponse in surveys. Springer
10.
Zurück zum Zitat Sweeney PD, Shaeffer DE, Golin S (1982) Pleasant events, unpleasant events, and depression. J Pers Soc Psychol 43(1):136–144CrossRef Sweeney PD, Shaeffer DE, Golin S (1982) Pleasant events, unpleasant events, and depression. J Pers Soc Psychol 43(1):136–144CrossRef
11.
Zurück zum Zitat Kivimäki M et al (2000) Sense of coherence and health: evidence from two cross-lagged longitudinal samples. Soc Sci Med 50(4):583–597CrossRef Kivimäki M et al (2000) Sense of coherence and health: evidence from two cross-lagged longitudinal samples. Soc Sci Med 50(4):583–597CrossRef
12.
13.
Zurück zum Zitat Chen W, Srinivasan SR, Berenson GS (2008) Path analysis of metabolic syndrome components in black versus white children, adolescents, and adults: the Bogalusa Heart Study. Ann Epidemiol 18(2):85–91CrossRef Chen W, Srinivasan SR, Berenson GS (2008) Path analysis of metabolic syndrome components in black versus white children, adolescents, and adults: the Bogalusa Heart Study. Ann Epidemiol 18(2):85–91CrossRef
14.
Zurück zum Zitat Jöreskog KG, Sörbom D (1993) LISREL 8: structural equation modeling with the SIMPLIS command language. Scientific Software International, Chicago Jöreskog KG, Sörbom D (1993) LISREL 8: structural equation modeling with the SIMPLIS command language. Scientific Software International, Chicago
15.
Zurück zum Zitat Jöreskog KG, Sörbom D (2001) LISREL8: user’s reference guide. Scientific Software International, Chicago Jöreskog KG, Sörbom D (2001) LISREL8: user’s reference guide. Scientific Software International, Chicago
16.
Zurück zum Zitat Hu LT, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure anaysis: conventional criteria versus new alternatives. Struct Equ Modeling A 6(1):1–55CrossRef Hu LT, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure anaysis: conventional criteria versus new alternatives. Struct Equ Modeling A 6(1):1–55CrossRef
17.
Zurück zum Zitat Karaca U et al (2014) Microvascular dysfunction as a link between obesity, insulin resistance and hypertension. Diabetes Res Clin Pract 103(3):382–387CrossRef Karaca U et al (2014) Microvascular dysfunction as a link between obesity, insulin resistance and hypertension. Diabetes Res Clin Pract 103(3):382–387CrossRef
18.
Zurück zum Zitat Scalia R (2013) The microcirculation in adipose tissue inflammation. Rev Endocr Metab Disord 14(1):69–76CrossRef Scalia R (2013) The microcirculation in adipose tissue inflammation. Rev Endocr Metab Disord 14(1):69–76CrossRef
19.
Zurück zum Zitat Bakker W et al (2008) Protein kinase C theta activation induces insulin-mediated constriction of muscle resistance arteries. Diabetes 57(3):706–713CrossRef Bakker W et al (2008) Protein kinase C theta activation induces insulin-mediated constriction of muscle resistance arteries. Diabetes 57(3):706–713CrossRef
20.
Zurück zum Zitat Yudkin JS, Eringa E, Stehouwer CD (2005) “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365(9473):1817–1820CrossRef Yudkin JS, Eringa E, Stehouwer CD (2005) “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365(9473):1817–1820CrossRef
21.
Zurück zum Zitat Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444(7121):840–846CrossRef Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444(7121):840–846CrossRef
22.
Zurück zum Zitat Serné EH et al (2001) Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 38(2):238–242CrossRef Serné EH et al (2001) Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 38(2):238–242CrossRef
23.
Zurück zum Zitat Levy BI et al (2001) Microcirculation in hypertension: a new target for treatment? Circulation 104(6):735–740CrossRef Levy BI et al (2001) Microcirculation in hypertension: a new target for treatment? Circulation 104(6):735–740CrossRef
24.
Zurück zum Zitat Montani JP et al (2002) Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 26(Suppl 2):S28-38CrossRef Montani JP et al (2002) Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 26(Suppl 2):S28-38CrossRef
Metadaten
Titel
Temporal and mediation relations of weight loss, and changes in insulin resistance and blood pressure in response to 2-year weight-loss diet interventions: the POUNDS Lost trial
verfasst von
Liyuan Han
Tao Zhang
Dingyun You
Wei Chen
George Bray
Frank Sacks
Lu Qi
Publikationsdatum
28.07.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 1/2022
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-021-02643-8

Weitere Artikel der Ausgabe 1/2022

European Journal of Nutrition 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.